Farther Finance Advisors’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$306 Sell
160
-446
-74% -$840 ﹤0.01% 5818
2026
Q2
$792 Buy
606
+297
+96% +$409 ﹤0.01% 5427
2026
Q1
$396 Buy
309
+214
+225% +$354 ﹤0.01% 5321
2025
Q4
$210 Hold
95
– – ﹤0.01% 5206
2025
Q3
$154 Buy
95
+94
+9,400% +$197 ﹤0.01% 4774
2025
Q2
$3 Sell
1
-1
-50% -$4 ﹤0.01% 4474
2025
Q1
$14 Hold
2
– – ﹤0.01% 4210
2024
Q4
$14 Hold
2
– – ﹤0.01% 3953
2024
Q3
$17 Hold
2
– – ﹤0.01% 3931
2024
Q2
$12 Sell
2
-2
-50% -$15 ﹤0.01% 3775
2024
Q1
$37 Sell
4
-41
-91% -$481 ﹤0.01% 3489
2023
Q4
$574 Buy
+45
New +$469 ﹤0.01% 2929

Other funds holding LUNG

Farther Finance Advisors's LUNG Position: Q3 2026 in Review

Farther Finance Advisors reduced its Pulmonx (LUNG) stake by 74% in Q3 2026, selling an estimated $840 and leaving 160 shares worth $306. The position accounts for ﹤0.01% of the portfolio, ranked #5818.

Farther Finance Advisors first reported a position in LUNG in Q4 2023 and has held it in 12 quarters since. The position peaked at $792 in Q2 2026. 5 funds tracked by Wall St. Rank hold LUNG as of Q3 2026.

  • Farther Finance Advisors held 160 shares of Pulmonx worth $306 as of Q3 2026.
  • Farther Finance Advisors sold 446 Pulmonx shares in Q3 2026, an estimated $840.
  • Pulmonx made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5818 holding.
  • Farther Finance Advisors first reported a position in Pulmonx in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Pulmonx position peaked at $792 in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Pulmonx as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.